References - Physics bibliographies - in Harvard style

In-text: (Fisher et al., 2008)

Your Bibliography: Fisher, N., Jan Danser, A., Nussberger, J., Dole, W. and Hollenberg, N., 2008. Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans. Circulation, 117(25), pp.3199-3205.

In-text: (Gandhi, Srinivasan and Akarte, 2012)

Your Bibliography: Gandhi, S., Srinivasan, B. and Akarte, A., 2012. Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats. Journal of the Renin-Angiotensin-Aldosterone System, 14(1), pp.3-13.

In-text: (Gheorghiade et al., 2013)

Your Bibliography: Gheorghiade, M., Bohm, M., Greene, S., Fonarow, G., Lewis, E., Zannad, F., Solomon, S., Baschiera, F., Botha, J., Hua, T., Gimpelewicz, C., Jaumont, X., Lesogor, A. and Maggioni, A., 2013. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA, 309, pp.1125-1135.

In-text: (Jamerson et al., 2008)

Your Bibliography: Jamerson, K., Weber, M., Bakris, G., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M. and Velazquez, E., 2008. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. New England Journal of Medicine, 359(23), pp.2417-2428.

In-text: (Kallergis et al., 2008)

Your Bibliography: Kallergis, E., Manios, E., Kanoupakis, E., Mavrakis, H., Arfanakis, D., Maliaraki, N., Lathourakis, C., Chlouverakis, G. and Vardas, P., 2008. Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial Fibrillation. Journal of the American College of Cardiology, 52(3), pp.211-215.

In-text: (Krum and Maggioni, 2010)

Your Bibliography: Krum, H. and Maggioni, A., 2010. Renin Inhibitors in Chronic Heart Failure: The Aliskiren Observation of Heart Failure Treatment Study in Context. Clinical Cardiology, 33(9), pp.536-541.

In-text: (Kuriyama et al., 2013)

Your Bibliography: Kuriyama, S., Yokoyama, K., Hara, Y., Sugano, N., Yokoo, T. and Hosoya, T., 2013. Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study. Clinical and Experimental Nephrology, 18(5), pp.821-830.

In-text: (Mahfoz et al., 2016)

Your Bibliography: Mahfoz, A., El-Latif, H., Ahmed, L., Hassanein, N. and Shoka, A., 2016. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 389(12), pp.1315-1324.

In-text: (McMurray et al., 2008)

Your Bibliography: McMurray, J., Pitt, B., Latini, R., Maggioni, A., Solomon, S., Keefe, D., Ford, J., Verma, A. and Lewsey, J., 2008. Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure. Circulation: Heart Failure, 1(1), pp.17-24.

In-text: (Morisawa et al., 2017)

Your Bibliography: Morisawa, N., Sugano, N., Yamakawa, T., Kuriyama, S. and Yokoo, T., 2017. Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension. CEN Case Reports, 6(1), pp.66-73.

In-text: (Neuman et al., 2007)

Your Bibliography: Neuman, R., Bloom, H., Shukrullah, I., Darrow, L., Kleinbaum, D., Jones, D. and Dudley, S., 2007. Oxidative Stress Markers Are Associated with Persistent Atrial Fibrillation. Clinical Chemistry, 53(9), pp.1652-1657.

In-text: (Ribeiro-Oliveira Jr et al., 2008)

Your Bibliography: Ribeiro-Oliveira Jr, A., Nogueira, A., Pereira, R., Boas, W., Dos Santos, R. and Simões e Silva, A., 2008. The renin-angiotensin system and diabetes: an update. Vascular Health Risk Management, 4(4), pp.787-803.

In-text: (Santos et al., 2007)

Your Bibliography: Santos, S., Fernandes, L., Mario, E., Ferreira, A., Porto, L., Alvarez-Leite, J., Botion, L., Bader, M., Alenina, N. and Santos, R., 2007. Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism. Diabetes, 57(2), pp.340-347.

In-text: (Solomon et al., 2009)

Your Bibliography: Solomon, S., Appelbaum, E., Manning, W., Verma, A., Berglund, T., Lukashevich, V., Cherif Papst, C., Smith, B. and Dahlof, B., 2009. Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy. Circulation, 119(4), pp.530-537.

In-text: (Takei, Ichikawa and Kijima, 2015)

Your Bibliography: Takei, Y., Ichikawa, M. and Kijima, Y., 2015. Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation. Journal of Arrhythmia, 31(2), pp.76-77.